Newstral
Article
Sydney Morning Herald on 2016-02-26 00:48
Pfizer seen avoiding $48 billion in tax through Allergan merger
Related news
- White House Tax Moves Sink Pfizer-Allergan Mergerbhcourier.com
- New tax-inversion rules kill proposed Allergan-Pfizer merger (+video)heralddemocrat.com
- CPfizer-Allergan merger: 10 things to know about corporate inversionscontracostatimes.com
- Pfizer and Allergan agree £106 billion mergerexpressandstar.com
- $160 billion Pfizer-Allergan merger raises outcryThe Fayetteville Observer
- Allergan, Pfizer call off proposed $160B mergerTimesDaily.com
- Pfizer drops merger with Botox maker Allergan after US tax clampdownexpressandstar.com
- Allergan-Pfizer deal could be the biggest merger this yearLA Times
- Pfizer, Allergan call off record $160 billion mergerkansascity.com
- Pfizer and Allergan Near $150 Billion Merger DealThe Day
- Drugmakers Pfizer, Allergan reportedly on brink of $150 billion mergertriblive.com
- Pfizer and Allergan near $150 billion merger dealStar Tribune
- Clinton criticizes Pfizer-Allergan merger, calls for inversions crackdownPOLITICO
- Pfizer and Allergan's $160-billion pharmaceutical merger puts new twist on tax-avoiding inversionsLA Times
- Pfizer, Allergan agree to mergernwaonline.com
- Pfizer scraps $160bn Allergan dealBBC
- Pfizer, Allergan merger talks raise tax hacklesReuters